Related Experiment Videos
Central retinal vein occlusion in sickle cell disease
Syed Hasan1, Mamoon Elbedawi, Oswaldo Castro
1Department of Medicine, Center for Sickle Cell Disease, Howard University, Washington, DC 20059, USA. syedphasan@hotmail.com
Southern Medical Journal
|February 26, 2004
Summary
Central retinal vein occlusion is a rare complication in sickle cell anemia patients. This case highlights protein S deficiency and iron deficiency as potential risk factors, with anticoagulation therapy aiding vision recovery.
Area of Science:
- Ophthalmology
- Hematology
- Vascular Medicine
Background:
- Sickle cell anemia is a genetic blood disorder associated with various vascular complications.
- Central retinal vein occlusion (CRVO) is a serious condition affecting vision, typically seen in older individuals.
- CRVO has not been previously documented in patients with sickle cell anemia.
Observation:
- A 31-year-old male patient with a diagnosis of sickle cell anemia presented with symptoms of central retinal vein occlusion.
- The patient's medical history revealed coexisting protein S deficiency and iron deficiency.
Findings:
- The development of central retinal vein occlusion in this young patient with sickle cell anemia is a novel observation.
- Protein S deficiency and iron deficiency were identified as potential contributing risk factors for the CRVO in this case.
- Anticoagulation therapy was initiated as the treatment for the central retinal vein occlusion.
Implications:
- This case suggests a potential link between sickle cell anemia, protein S deficiency, iron deficiency, and central retinal vein occlusion.
- Early identification and management of these risk factors may be crucial for preventing or treating vision-threatening complications in sickle cell anemia patients.
- Further research is warranted to elucidate the underlying mechanisms and establish definitive management guidelines for CRVO in sickle cell anemia.